REPORT ID 435

EMEA (Europe, Middle East and Africa) Animal Pharmaceutical Market Report 2017

Publish Date
01-Dec-17
Pages
118
Format
Electronic (PDF)

In this report, the EMEA Animal Pharmaceutical market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Animal Pharmaceutical for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Animal Pharmaceutical market competition by top manufacturers/players, with Animal Pharmaceutical sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Zoetis
    Merck
    Merial
    Elanco
    Bayer Animal Health
    Boehringer Ingelheim Vetmedica
    Virbac
    Ceva Sante Animale
    V?toquinol
    Jurox
    MSD Animal Health Australia
    PARNELL
    CAHIC
    Ringpu Biology

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    Vaccine
    Veterinary Drugs
    Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Companion Animal
    Poultry
    Other

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Animal Pharmaceutical Market Report 2017
1 Animal Pharmaceutical Overview
    1.1 Product Overview and Scope of Animal Pharmaceutical
    1.2 Classification of Animal Pharmaceutical
        1.2.1 EMEA Animal Pharmaceutical Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Animal Pharmaceutical Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Vaccine
        1.2.4 Veterinary Drugs
        1.2.5 Other
    1.3 EMEA Animal Pharmaceutical Market by Application/End Users
        1.3.1 EMEA Animal Pharmaceutical Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 Companion Animal
        1.3.3 Poultry
        1.3.4 Other
    1.4 EMEA Animal Pharmaceutical Market by Region
        1.4.1 EMEA Animal Pharmaceutical Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Animal Pharmaceutical (2012-2022)
        1.5.1 EMEA Animal Pharmaceutical Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Animal Pharmaceutical Revenue and Growth Rate (2012-2022)

2 EMEA Animal Pharmaceutical Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Animal Pharmaceutical Market Competition by Players/Manufacturers
        2.1.1 EMEA Animal Pharmaceutical Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Animal Pharmaceutical Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Animal Pharmaceutical Sale Price by Players (2012-2017)
    2.2 EMEA Animal Pharmaceutical (Volume and Value) by Type/Product Category
        2.2.1 EMEA Animal Pharmaceutical Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Animal Pharmaceutical Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Animal Pharmaceutical Sale Price by Type (2012-2017)
    2.3 EMEA Animal Pharmaceutical (Volume) by Application
    2.4 EMEA Animal Pharmaceutical (Volume and Value) by Region
        2.4.1 EMEA Animal Pharmaceutical Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Animal Pharmaceutical Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Animal Pharmaceutical Sales Price by Region (2012-2017)

3 Europe Animal Pharmaceutical (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Animal Pharmaceutical Sales and Value (2012-2017)
        3.1.1 Europe Animal Pharmaceutical Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Animal Pharmaceutical Revenue and Growth Rate (2012-2017)
    3.2 Europe Animal Pharmaceutical Sales and Market Share by Type
    3.3 Europe Animal Pharmaceutical Sales and Market Share by Application
    3.4 Europe Animal Pharmaceutical Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Animal Pharmaceutical Sales Volume by Countries (2012-2017)
        3.4.2 Europe Animal Pharmaceutical Revenue by Countries (2012-2017)
        3.4.3 Germany Animal Pharmaceutical Sales and Growth Rate (2012-2017)
        3.4.4 France Animal Pharmaceutical Sales and Growth Rate (2012-2017)
        3.4.5 UK Animal Pharmaceutical Sales and Growth Rate (2012-2017)
        3.4.6 Russia Animal Pharmaceutical Sales and Growth Rate (2012-2017)
        3.4.7 Italy Animal Pharmaceutical Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Animal Pharmaceutical Sales and Growth Rate (2012-2017)

4 Middle East Animal Pharmaceutical (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Animal Pharmaceutical Sales and Value (2012-2017)
        4.1.1 Middle East Animal Pharmaceutical Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Animal Pharmaceutical Revenue and Growth Rate (2012-2017)
    4.2 Middle East Animal Pharmaceutical Sales and Market Share by Type
    4.3 Middle East Animal Pharmaceutical Sales and Market Share by Application
    4.4 Middle East Animal Pharmaceutical Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Animal Pharmaceutical Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Animal Pharmaceutical Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Animal Pharmaceutical Sales and Growth Rate (2012-2017)
        4.4.4 Israel Animal Pharmaceutical Sales and Growth Rate (2012-2017)
        4.4.5 UAE Animal Pharmaceutical Sales and Growth Rate (2012-2017)
        4.4.6 Iran Animal Pharmaceutical Sales and Growth Rate (2012-2017)

5 Africa Animal Pharmaceutical (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Animal Pharmaceutical Sales and Value (2012-2017)
        5.1.1 Africa Animal Pharmaceutical Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Animal Pharmaceutical Revenue and Growth Rate (2012-2017)
    5.2 Africa Animal Pharmaceutical Sales and Market Share by Type
    5.3 Africa Animal Pharmaceutical Sales and Market Share by Application
    5.4 Africa Animal Pharmaceutical Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Animal Pharmaceutical Sales Volume by Countries (2012-2017)
        5.4.2 Africa Animal Pharmaceutical Revenue by Countries (2012-2017)
        5.4.3 South Africa Animal Pharmaceutical Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Animal Pharmaceutical Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Animal Pharmaceutical Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Animal Pharmaceutical Sales and Growth Rate (2012-2017)

6 EMEA Animal Pharmaceutical Manufacturers/Players Profiles and Sales Data
    6.1 Zoetis
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Animal Pharmaceutical Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Zoetis Animal Pharmaceutical Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Merck
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Animal Pharmaceutical Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Merck Animal Pharmaceutical Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Merial
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Animal Pharmaceutical Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Merial Animal Pharmaceutical Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Elanco
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Animal Pharmaceutical Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Elanco Animal Pharmaceutical Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Bayer Animal Health
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Animal Pharmaceutical Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Bayer Animal Health Animal Pharmaceutical Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Boehringer Ingelheim Vetmedica
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Animal Pharmaceutical Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Boehringer Ingelheim Vetmedica Animal Pharmaceutical Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Virbac
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Animal Pharmaceutical Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Virbac Animal Pharmaceutical Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Ceva Sante Animale
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Animal Pharmaceutical Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Ceva Sante Animale Animal Pharmaceutical Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 V?toquinol
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Animal Pharmaceutical Product Type, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 V?toquinol Animal Pharmaceutical Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Jurox
        6.10.1 Company Basic Information, Manufacturing Base and Competitors
        6.10.2 Animal Pharmaceutical Product Type, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Jurox Animal Pharmaceutical Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview
    6.11 MSD Animal Health Australia
    6.12 PARNELL
    6.13 CAHIC
    6.14 Ringpu Biology

7 Animal Pharmaceutical Manufacturing Cost Analysis
    7.1 Animal Pharmaceutical Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Animal Pharmaceutical

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Animal Pharmaceutical Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Animal Pharmaceutical Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Animal Pharmaceutical Market Forecast (2017-2022)
    11.1 EMEA Animal Pharmaceutical Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Animal Pharmaceutical Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Animal Pharmaceutical Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Animal Pharmaceutical Price and Trend Forecast (2017-2022)
    11.2 EMEA Animal Pharmaceutical Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Animal Pharmaceutical Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Animal Pharmaceutical Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Animal Pharmaceutical Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Animal Pharmaceutical Sales Forecast by Type (2017-2022)
    11.7 EMEA Animal Pharmaceutical Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer